Evidence map›Paper›PMID 37648841›Full record

ArticleMolecular neurobiology2024

Locomotor Behavior and Memory Dysfunction Induced by 3-Nitropropionic Acid in Adult Zebrafish: Modulation of Dopaminergic Signaling.

Melissa Talita Wiprich, Rafaela da Rosa Vasques, Darlan Gusso, Gabriel Rübensam, Luiza Wilges Kist, Mauricio Reis Bogo, Carla Denise Bonan

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Melissa Talita WiprichPrograma de Pós-Graduação Em Medicina E Ciências da Saúde, Escola de Medicina, Pontifícia Universidade Católica Do Rio Grande Do Sul, Porto Alegre, RS, Brazil.
Rafaela da Rosa VasquesLaboratório de Neuroquímica E Psicofarmacologia, Escola de Ciências da Saúde E da Vida, Pontifícia Universidade Católica Do Rio Grande Do Sul, Porto Alegre, RS, Brazil.
Darlan GussoLaboratório de Neuroquímica E Psicofarmacologia, Escola de Ciências da Saúde E da Vida, Pontifícia Universidade Católica Do Rio Grande Do Sul, Porto Alegre, RS, Brazil.
Gabriel RübensamCentro de Pesquisa Em Toxicologia E Farmacologia, Escola de Ciências da Saúde E da Vida, Pontifícia Universidade Católica Do Rio Grande Do Sul, Porto Alegre, RS, Brazil.
Luiza Wilges KistPrograma de Pós-Graduação Em Biologia Celular E Molecular, Escola de Ciências da Saúde E da Vida, Pontifícia Universidade Católica Do Rio Grande Do Sul, Porto Alegre, RS, Brazil.
Mauricio Reis BogoPrograma de Pós-Graduação Em Medicina E Ciências da Saúde, Escola de Medicina, Pontifícia Universidade Católica Do Rio Grande Do Sul, Porto Alegre, RS, Brazil.
Carla Denise BonanPrograma de Pós-Graduação Em Medicina E Ciências da Saúde, Escola de Medicina, Pontifícia Universidade Católica Do Rio Grande Do Sul, Porto Alegre, RS, Brazil. cbonan@pucrs.br.ORCID http://orcid.org/0000-0001-9715-6244
Pontifícia Universidade Católica do Rio Grande do Sul · BRInstituto Nacional de Ciência e Tecnologia de Doenças Tropicais · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 140290/2019-2Conselho Nacional de Desenvolvimento Científico e Tecnológico 304450/2019-7Conselho Nacional de Desenvolvimento Científico e Tecnológico 420695/2018-4Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 001Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul 17/2551-0000977-0
6 · The paper itself

Abstract

Huntington's disease (HD) is a progressive neurodegenerative disease characterized by neuropsychiatric disturbance, cognitive impairment, and locomotor dysfunction. In the early stage (chorea) of HD, expression of dopamine D

Indexed as

DopamineNeurodegenerative DiseasesNitro CompoundsPropionatesSalicylamidesAnimalsDopamine AgonistsHypokinesiaMemory DisordersQuinpiroleReceptors, Dopamine D1Receptors, Dopamine D2Zebrafish3-nitropropionic acidDopamineDopamine AgonistseticloprideNitro CompoundsPropionatesQuinpiroleReceptors, Dopamine D1Receptors, Dopamine D2Salicylamides3-Nitropropionic acidDopaminergic systemHuntington’s diseaseLocomotor dysfunctionMemory lossZebrafish

Identifiers

PMID37648841
OpenAlexW4386275965

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.